stella
beta
GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1） — Stella
Recruiting
Back to Advanced Biliary Tract Cancer trials
Trial locations
(1 site)
China
Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov